We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+8.79%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$5.67B
AUM Growth
+$449M
Cap. Flow
+$100M
Cap. Flow %
1.77%
Top 10 Hldgs %
21.33%
Holding
617
New
29
Increased
183
Reduced
116
Closed
41

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$44.1M
2
ACGL icon
Arch Capital
ACGL
+$36.2M
3
XYL icon
Xylem
XYL
+$35.6M
4
AME icon
Ametek
AME
+$12M
5
GWW icon
W.W. Grainger
GWW
+$11.2M

Sector Composition

Rank Sector Weight
1 Technology 32.22%
2 Healthcare 19.27%
3 Consumer Discretionary 10.8%
4 Industrials 9.16%
5 Financials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BA icon
526
Boeing
BA
$171B
$61.2K ﹤0.01%
290
TAK icon
527
Takeda Pharmaceutical
TAK
$54.6B
$57.7K ﹤0.01%
3,674
OLED icon
528
Universal Display
OLED
$3.68B
$56.9K ﹤0.01%
395
CRBU icon
529
Caribou Biosciences
CRBU
$145M
$56.7K ﹤0.01%
13,900
SEER icon
530
Seer Inc
SEER
$122M
$56.2K ﹤0.01%
13,000
RTX icon
531
RTX Corp
RTX
$290B
$53.9K ﹤0.01%
550
+170
+45% +$16.6K
LMT icon
532
Lockheed Martin
LMT
$134B
$52.9K ﹤0.01%
115
+35
+44% +$16.2K
GD icon
533
General Dynamics
GD
$104B
$50.6K ﹤0.01%
235
+20
+9% +$4.32K
NOC icon
534
Northrop Grumman
NOC
$77.1B
$50.1K ﹤0.01%
110
+10
+10% +$4.54K
TSVT
535
DELISTED
2seventy bio
TSVT
$49.9K ﹤0.01%
4,999
TSLA icon
536
Tesla
TSLA
$1.23T
$49.7K ﹤0.01%
190
SGMO
537
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$47.5K ﹤0.01%
38,000
KEYS icon
538
Keysight
KEYS
$54.5B
$47.1K ﹤0.01%
281
IYG icon
539
iShares US Financial Services ETF
IYG
$2.16B
$46.9K ﹤0.01%
897
VZ icon
540
Verizon
VZ
$195B
$43.2K ﹤0.01%
1,162
CDXS icon
541
Codexis
CDXS
$151M
$42.8K ﹤0.01%
15,500
NSTG
542
DELISTED
NanoString Technologies, Inc.
NSTG
$39.3K ﹤0.01%
9,900
ATRA icon
543
Atara Biotherapeutics
ATRA
$75.5M
$35.9K ﹤0.01%
880
SCHW
544
Charles Schwab
SCHW
$183B
$33K ﹤0.01%
582
LENZ
545
LENZ Therapeutics
LENZ
$166M
$30.8K ﹤0.01%
1,700
IXC icon
546
iShares Global Energy ETF
IXC
$2.79B
$29.8K ﹤0.01%
800
CCCC icon
547
C4 Therapeutics
CCCC
$385M
$29.4K ﹤0.01%
10,700
AU icon
548
AngloGold Ashanti
AU
$40.1B
$28.5K ﹤0.01%
1,350
NKTR icon
549
Nektar Therapeutics
NKTR
$2.39B
$27K ﹤0.01%
3,120
EOG icon
550
EOG Resources
EOG
$79.2B
$24K ﹤0.01%
210
-10,000
-98% -$1.14M

Similar funds

Erste Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Erste Asset Management held 617 positions worth $5.67B, up 8.6% from $5.22B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Erste Asset Management's Q2 2023 filing shows 29 new, 183 increased, 116 reduced and 41 closed positions. Its largest new stake was UiPath: 660,000 shares worth $11M. The largest sale was Evoqua Water Technologies Corp. Common Stock, an estimated $37.3M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Erste Asset Management's largest Q2 2023 buy was UiPath: 660,000 shares worth $11M.
  • Erste Asset Management added most to AstraZeneca in Q2 2023, an estimated $44.1M increase.
  • Erste Asset Management's biggest Q2 2023 reduction was Progressive, cutting an estimated $31.7M.
  • Erste Asset Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $37.3M.
  • Erste Asset Management's ten largest holdings make up 21% of its $5.67B portfolio in Q2 2023.
  • Erste Asset Management opened 29 new positions and closed 41 in Q2 2023.
  • Erste Asset Management's portfolio value rose 8.6% quarter-over-quarter to $5.67B.

Based on Erste Asset Management's 13F filing for Q2 2023, filed 26 Nov 2024.